Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study - Wikidata - wikimedia - TriplyDB

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study

http://www.wikidata.org/entity/Q28472479

about

Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia Oxidative stress in schizophrenia A Comprehensive Review of the (1)H-MRS Metabolite Spectrum in Autism Spectrum Disorder Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins Molecular substrates of schizophrenia: homeostatic signaling to connectivity Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.Neonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood: clinical rescue by d-serine Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Oxidative stress and schizophrenia: recent breakthroughs from an old story Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.Meta-analysis of oxidative stress in schizophrenia.Central nervous system uptake of intranasal glutathione in Parkinson's disease.Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.Antioxidant defense system and family environment in adolescents with family history of psychosis.Oxidative stress in schizophrenia: an integrated approach.Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism Neurobiology of schizophrenia onset.Antioxidants as potential therapeutics for neuropsychiatric disorders.Glutathione dysregulation and the etiology and progression of human diseases.Measurement of glutathione in normal volunteers and stroke patients at 3T using J-difference spectroscopy with minimized subtraction errors.Glutathione metabolism in the prefrontal brain of adults with high-functioning autism spectrum disorder: an MRS study.Reproducibility of phase rotation STEAM at 3T: focus on glutathione.Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.Pharmacotherapy for treatment-refractory schizophrenia.The glutathione system: a new drug target in neuroimmune disorders.Targeting of NMDA receptors in new treatments for schizophrenia.Echo time optimization for J-difference editing of glutathione at 3T.Neuroprotection in Schizophrenia and Its Therapeutic Implications.Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis Quantification of glutathione in the human brain by MR spectroscopy at 3 Tesla: Comparison of PRESS and MEGA-PRESS.Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia.Measuring Cerebral and Cerebellar Glutathione in Children Using 1H MEGA-PRESS MRS.Simultaneous detection of glutathione and lactate using spectral editing at 3 T.Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs.

P2860

Q21562668-B7FF136C-1BCA-48AF-BDC5-EDDE4E0A6B78 Q24595660-81F502AA-D60C-430B-A269-AAEC201BD323 Q26751201-427C78F7-8F00-4FA2-A078-AEF18A439445 Q26865740-BDF08DA1-0D4C-4459-AC2F-D1CB0BAA6CCB Q28083121-19A155F5-58ED-4F2A-8F27-CCA9F0AB277C Q28382991-F571DE72-E36C-45ED-AF8A-6ED81EB48D34 Q30383611-C500BF06-E567-47D5-A34C-38961AF954F8 Q30440988-CF466C44-C3CE-44BB-A51F-876E9DC46808 Q30455182-D4ED1E8D-4C7D-46C6-A761-68CFBF555B52 Q30458051-F3D444DB-E25F-42AA-8B81-C6C0F527762A Q30685335-EE8A05BD-E1CD-4A4B-9683-93FAC17879E8 Q30774039-A92CBDFC-246C-4A98-B071-ACC0AC177E45 Q31108616-15CC3BFE-1740-48AD-B62A-B400696FD3D2 Q33601360-CF5E5D13-B21C-4861-AF61-5C8CBB84DDD2 Q33917288-3AD9B165-ED78-493E-A06A-715507F3C7F2 Q33979025-A1AAFE83-C58D-4105-9899-8413224CD956 Q34351880-275D3992-9985-4274-B96D-33DF857D244E Q34372998-9F71EFB8-1881-4805-95E5-72FC4057B4A7 Q34479923-7751B249-7BD4-4369-AF4E-16688CE28351 Q34494844-BA03F153-E1E4-4694-9E07-6C4C402E920D Q34599738-FF6121DE-9D71-4C7D-9AE1-32C4336DDB72 Q35660832-705E9F34-68E3-4911-89FB-37C539A30901 Q36736055-ECD224E7-1F7C-4D28-BC46-9976B10EC13E Q37372896-F9EFE861-6BD0-4CFE-ABA2-5CD997E77D6E Q37409476-C59840CE-3E7F-4086-A28E-E45D0A43BCB0 Q37700799-3E1D45B3-63B7-4E5B-9F3D-076EC1C6BE33 Q37716923-963E6F96-0156-4630-B405-CA3916B32407 Q37794502-B9552243-E172-48DB-9DC1-24C0BBD8EEBC Q37831352-269E65EB-5BA8-491F-AC09-70743D5A9184 Q38206126-E58BD130-E4B1-40D1-A989-0C9BFDA48CB0 Q38223276-35C4D8BC-A3C9-4BD4-8EC4-A2F239F0D47B Q39966232-B3E5969A-333B-4A59-9514-EF85A4D4AF0E Q41449646-85AA1F78-8451-4526-81AA-A84FE2447E7A Q41687474-C3D64FC6-D832-4931-9FB2-A9AA4B422CB1 Q41703320-078C5F19-ED0C-401C-AF3E-339B7B0FB2F7 Q43006340-F9AF1BEA-0324-4609-9166-DF003FB93261 Q43801006-7F54188C-2DD4-4756-87B9-4CB887754309 Q47307234-F87AA19C-3F7C-4A29-90DB-D00AAA137C30 Q47643702-AE952920-7373-4E67-9D76-8461EE687E08 Q49348765-90AD6988-4E43-4106-A40D-212751649AF9

P2860

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study

http://www.wikidata.org/entity/Q28472479

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@ast

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@en

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@nl

type

label

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@ast

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@en

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@nl

prefLabel

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@ast

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@en

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@nl

P1433

Q28472479-D2288386-478F-4687-95B7-10ECDCF75FE1

P1476

Q28472479-261A698F-1683-4EC2-B966-FEF8EE581D0D

P2093

Q28472479-11E42D3E-99C6-4E81-A492-39A0BF5653FE

Q28472479-1A397A4B-5BEC-477E-B43A-F61713C9D984

Q28472479-533E0233-B3FE-4946-B41F-27811DFA9BE1

Q28472479-991DAF05-6116-4274-A00A-D1C365348031

Q28472479-9F23159F-F183-4F19-AC10-C28B657D574C

Q28472479-A27A290D-4E8F-41AE-A69B-31CC43384834

Q28472479-BF6134E1-CBF5-48A8-9953-355CDE5A3243

Q28472479-DD38E821-362B-4E58-8F43-38956D9ED5BE

Q28472479-EE76924B-15E7-495B-A6B7-AF6782437655

P2860

Q28472479-13268F19-D1EA-4449-816F-19762967FCCA

Q28472479-134D084D-EE51-4BCA-9909-88671FD1695F

Q28472479-19E63B89-BEDE-472E-8531-F8B7901C7559

Q28472479-3386AA85-F488-4CAD-8C7A-E1CC547A78FC

Q28472479-3411FFA3-78C7-4BCF-B0C8-5F1BC786F100

Q28472479-3D50949C-5E8A-4378-803F-55AF94A6E6AE

Q28472479-5F3A1860-5DBD-4340-9EF1-707C7F1F7B5B

Q28472479-66ADC32D-D276-49AE-913F-E88209AEFE4E

Q28472479-702AF1B2-F09D-417A-801E-9347A4DCFD1D

Q28472479-711EE953-C422-4708-9E6A-CC5C2906F960

P304

Q28472479-0B298BBE-73FC-4102-A6F7-77A4020DAAF4

P31

Q28472479-731EA1BF-247D-4C00-9693-ADF00B3E2DFF

P356

Q28472479-E643C5A7-778C-47C4-A2F5-EA302C68B8E8

P407

Q28472479-6DEFCC33-3DB3-4B41-94E6-8C97122F327E

P433

Q28472479-6E871BA1-A7E5-44E8-AC8D-45FB2310D0DC

P478

Q28472479-DA76EAB5-CC13-4593-BF0F-1FF18BAEB75C

P50

Q28472479-28E47C3D-0D98-4E58-8449-844AC0D5EADC

Q28472479-33D4FAF5-6F46-499C-82DA-21D35997FB76

Q28472479-56F72FAA-0803-445B-A5D6-7E38A46E7262

P577

Q28472479-3706B803-FA79-4C46-A3A4-25B5F87DD1D7

P5875

Q28472479-002167DA-B081-4F8E-A20D-5FCB4475A125

P698

Q28472479-BFFFC09A-07A4-4464-9836-2A9EBD94E643

P921

Q28472479-12979E0E-187E-42A1-9A2E-1AA2F46605C6

Q28472479-E713C47C-C171-4EB5-96CC-8905C29F0604

P932

Q28472479-86F5B081-7E96-4E2D-A18C-E9CAD4801C9E

P356

JOURNAL.PONE.0001944

P1433

P1476

Negative correlation between b ...... hizophrenia: a 3T 1H-MRS study

@en

P2093

Eiji Shimizu

http://www.w3.org/2001/XMLSchema#string

Eiji Yoshitome

http://www.w3.org/2001/XMLSchema#string

Hiroi Nonaka

http://www.w3.org/2001/XMLSchema#string

Hiroo Ikehira

http://www.w3.org/2001/XMLSchema#string

Junichi Takanashi

http://www.w3.org/2001/XMLSchema#string

Masaomi Iyo

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Matsuda

http://www.w3.org/2001/XMLSchema#string

Yoko Kanazawa

http://www.w3.org/2001/XMLSchema#string

Yukihiko Shirayama

http://www.w3.org/2001/XMLSchema#string

P2860

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

Meeting of minds: the medial frontal cortex and social cognition

Recent advances in the phencyclidine model of schizophrenia

Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia.

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

Disorganization of semantic memory underlies alogia in schizophrenia: an analysis of verbal fluency performance in Japanese subjects.

Glutathione is an endogenous ligand of rat brain N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors.

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene

P304

e1944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0001944

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Daisuke Matsuzawa

P577

2008-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5455209

http://www.w3.org/2001/XMLSchema#string

P698

18398470

http://www.w3.org/2001/XMLSchema#string

P921

P932

2275307

http://www.w3.org/2001/XMLSchema#string